ELECTOR - eHealth in Rheumatology
Research type
Research Study
Full title
ELECTOR Treat-to-target via home-based disease activity monitoring of patients with rheumatoid arthritis: A 6 months multicentre, eHealth randomised, non-blinded, parallel-group, superiority trial
IRAS ID
241546
Contact name
Annette Winter
Contact email
Sponsor organisation
University of Oxford/Clinical Trials and Research Governance
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 11 months, 1 days
Research summary
Rheumatoid arthritis is a chronic autoimmune disease affecting approximately 1% of the population. RA is characterised by chronic joint pain and swelling, progressive and irreversible joint damage and disability. RA reduces life expectancy due to co-morbidities with decreased quality of life and functional impairment. The current therapeutic approach to managing patients with Rheumatoid arthritis is an aggressive pharmacological disease control through regular monitoring and appropriate adjustment of therapy to reach a target of remission or minimal/low disease activity.Currently patients are managed in a hospital setting with numerous scheduled visits required for Rheumatology health care practitioners to optimise their treatment. The study will recruit male/female RA hospital participants age 18-85 to see if home-based self-reported disease activity monitoring over a 6 month period can be an alternative to hospital based monitoring and improve treatment of rheumatoid arthritis.
REC name
South West - Cornwall & Plymouth Research Ethics Committee
REC reference
19/SW/0117
Date of REC Opinion
27 Jun 2019
REC opinion
Favourable Opinion